Maurizio Ceppi
Transgene (France)(FR)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Cancer Immunotherapy and Biomarkers, HER2/EGFR in Cancer Research, Peptidase Inhibition and Analysis, Immunotherapy and Immune Responses
Most-Cited Works
- → MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells(2009)704 cited
- → Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy(2019)256 cited
- → MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation(2008)247 cited
- → Multiple recent horizontal transfers of a large genomic region in cheese making fungi(2014)212 cited
- → Interaction of classical swine fever virus with dendritic cells(2004)91 cited
- → Protein phosphatase 1 subunit Ppp1r15a/GADD34 regulates cytokine production in polyinosinic:polycytidylic acid-stimulated dendritic cells(2012)87 cited
- → Selective enhancement of gene transfer by steroid-mediated gene delivery(2001)81 cited
- → Regulation of translation is required for dendritic cell function and survival during activation(2007)80 cited
- → Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer(2018)77 cited
- → First-in-Human Phase I Study of Lumretuzumab, a Glycoengineered Humanized Anti-HER3 Monoclonal Antibody, in Patients with Metastatic or Advanced HER3-Positive Solid Tumors(2015)75 cited